One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Phase 2 Trial
Jilg et al., Clinical Infectious Diseases, doi:10.1093/cid/ciad342
https://c19early.org/jilg.html